Table 2.
Adverse events during the treatment period.
| Placebo group, n = 61 |
Lithium group, n = 61 |
|||
|---|---|---|---|---|
| n | % | n | % | |
| Urinary symptoms | 0 | 0 | 2 | 3.28% |
| Polyuria | 0 | 2 | ||
| Gastrointestinal symptoms | 2 | 3.28% | 4 | 6.56% |
| Nausea | 1 | 2 | ||
| Vomiting | 0 | 1 | ||
| Decreased appetite | 1 | 1 | ||
| Neurological symptoms | 1 | 1.64% | 4 | 6.56% |
| Aggressive behavior | 0 | 1 | ||
| Epileptic seizures | 1 | 1 | ||
| Dullness | 0 | 1 | ||
| Hyperactivity | 0 | 1 | ||
| Other symptoms | 0 | 0 | 4 | 6.56% |
| Alopecia | 0 | 1 | ||
| Drooling | 0 | 1 | ||
| Hyperhidrosis | 0 | 1 | ||
| Nasoseptal surgery | 0 | 1 | ||
| Total | 3 | 4.92% | 14 | 21.31%a |
aThe 14 total events included 1 “nasoseptal surgery,” which was regarded as unrelated to lithium administration, so the total number of children who presented with side effects was 13 when the percentages were calculated.